Drew Ranieri

Stock Analyst at Morgan Stanley

(0.86)
# 2311
Out of 5,386 analysts
175
Total ratings
Success rate
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
ORGO Organogenesis Holdin...
Maintains: Equal-Weight
4 6
3.66 63.93% 4 Mar 5, 2025
GMED Globus Medical
Upgrades: Overweight
83 100
58.55 70.79% 12 Dec 2, 2024
SYK Stryker
Upgrades: Overweight
370 445
393.65 13.04% 9 Dec 2, 2024
SIBN SI-BONE
Maintains: Overweight
21 19
18.43 3.09% 15 Aug 6, 2024
IART Integra Lifesciences
Maintains: Underweight
24 27
12.29 119.69% 13 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
6 8
5.74 39.37% 12 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
26 22
24.67 -10.82% 16 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
10 8
10.69 -25.16% 13 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
19 16
11.07 44.53% 8 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
75 83
18.96 335.13% 10 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
10 8
n/a n/a 11 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
42 38
19.68 93.09% 9 Nov 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
88 96
73.99 29.75% 10 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
28 26
12.21 112.94% 8 May 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
290 295
170.81 72.71% 2 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
236 280
119.42 134.47% 5 Jan 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 5
6.76 -26.04% 6 Nov 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
72 70
30.41 130.19% 4 Oct 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
62 54
n/a n/a 1 Jul 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
325 300
533.62 -43.78% 6 Apr 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
130 148
n/a n/a 1 Aug 2, 2021